World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation is based on results from an ongoing pilot programme in Ghana, Kenya & Malawi that has reached more than 800 000 children since 2019.
The vaccine is developed by British drugmaker GlaxoSmithKline (GSK). Many vaccines exist against viruses and bacteria but this was the first time that the WHO recommended broad use of a vaccine against a human parasite. The vaccine acts against Plasmodium falciparum, one of five parasite species and the most deadly. The symptoms of malaria are fever, headaches, and muscle pain, then cycles of chills, fever, and sweating.
Important takeaways for all competitive exams:
The Indian Railways has announced that the Jammu-Shri Mata Vaishno Devi Katra rail section will…
India has surpassed the United States to become Bangladesh's second-largest trading partner as per the…
India's ambitious restoration mission Project Cheetah is showing the strong momentum as the India's cheetah…
The Bharat Forge has signed the MoU with the State Government of Andhra Pradesh to…
India has notified the new technical standards for petrol blended with up to 30% ethanol.…
The Indian Government has launched the Ayush Anudan Portal, which is a major digital initiative…